Creative Biolabs ADC Blog

Menu

Skip to content
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News

Monthly Archives: March 2021

29Mar/21

Fast-Tracking ADC Drugs Manufacturing and Production Technology

March 29, 2021UncategorizedADC Drugs, Antibody Conjugation Technique, DAR, site-specific conjugation, unnatural amino acid conjugatebioadc

When we get an ideal candidate for ADC, the next step is to consider how to scale it up. This step is important because it is directly related to the post-market marketRead More…

29Mar/21

Overview: Mechanism of Action of ADC

March 29, 2021UncategorizedAction of ADCbioadc

Specific Binding ADC drugs specifically bind to antigenic epitopes of cancer cells through their “guiding” antibodies, and enter into cancer cells through antigen-mediated endocytosis, then release the “warheads” – highly active cytotoxicRead More…

29Mar/21

Comprehensively Review Targets for ADC

March 29, 2021ReviewADC targets, CD19, CD30, CD37, Trop2bioadc

At present, ADC drugs are mainly used in the field of tumors, so antigenic targets are required to be highly expressed in tumor cells but with low or no expression in normalRead More…

Categories

Recent Posts

  • Targeting Drug-Resistant Breast Cancer with a Novel ADC
  • Aptamer-Drug Conjugates: The Next Frontier in Targeted Cancer Therapy Shows Encouraging Results
  • A New Hope for Cancer Therapy: How ADCs are Redefining Treatment
  • Hyaluronidase-Conjugated Liposomes May Effectively Target Pancreatic Cancer
  • Beyond the Magic Bullet: How Next-Generation Linkers are Rewriting the ADC Playbook

Archives

Contact Us

USA - UK

Copyright © Creative Biolabs ADC Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News